The Canadian Centre for Applied Research in Cancer Control (ARCC) is pleased to announce that its 13th annual conference, ARCC2024, will return to an In-Person format on May 16-17, 2024, following the 2024 CAHSPR Conference. The objective of this conference is to bridge a connection between researchers and decision-makers, using health economics, services, policy and ethics research to improve cancer control and the delivery of cancer care.
Abstracts Submission for ARCC2024 will open in December 2023
Formats: Oral, Poster, Panel
Abstract Deadline: Friday January 26, 2024
Presentation Notification: ~Week of March 11, 2024
*Abstract Guidelines Coming Soon!*
Questions? Contact us at email@example.com
ARCC will offer travel awards of up to $1000 for students and/or new professionals presenting at our conference – details to be posted soon, and applications are collected alongside abstract submission. In addition, we will offer presentation awards for top ranked presentations at ARCC2024.
To be eligible for an award, the student or new professional must be submitting an abstract to and presenting at ARCC2024. We will provide additional details in the coming weeks – and invite any suggestions you may have for how we can support trainees at ARCC2024. Email us at ARCC@cc-arcc.ca or contact Rebecca at Rebecca.Mercer@sunnybrook.ca
Registration for #ARCC2024 will open in January 2024!
ARCC will continue to support new professionals (defined as someone who received their final degree within the last 5 years) with discounted rates, and offer complimentary registrations to patients who wish to attend.
Non-member? Consider Joining today – membership is free!
Stay tuned for information about invited speakers as they are added!
Dr. Nicola Bai (ARCC Program Manager)
Nicola Bai is the interim Program Manager for the Canadian Centre for Applied Research in Cancer Control (ARCC). Nicola has extensive clinical research experience in oncology, and is very interested in cancer survivorship research and cost-effectiveness analysis in cancer treatment. Nicola is a physician by training from China. She also received PhD in Pharmacology from the University of British Columbia (UBC), and has recently completed Master of Health Science (focusing on Health Economics) from the School of Population and Public Health at UBC.
Dr. Kelvin Chan, MD, FRCP, MSc, PhD - (ARCC Co-Director)
Dr Kelvin Chan is a Medical Oncologist at the Sunnybrook Odette Cancer Centre, a Professor at the University of Toronto, and an Associate Scientist at the Sunnybrook Research Institute. He specializes in GI oncology and Head and Neck oncology. He has completed his PhD in Biostatistics (focusing on statistical methods in health economic evaluations) at the Dalla Lana School of Public Health, University of Toronto.
As a clinical epidemiologist and biostatistician, Dr. Chan’s research interests include health services research, health technology assessment, meta-analysis including network meta-analysis, cost-effectiveness analyses, and statistical methods research in health economics. He is the Co-Director at the Canadian Centre for Applied Research in Cancer Control (ARCC).
Professionally, Dr Chan has an interest in cancer drug reimbursement related issues. He is a member of multiple provincial and national committees related to cancer drug assessments and recommendations including membership at the pan-Canadian Oncology Drug Review (pCODR) Expert Review Committee (pERC), the Committee to Evaluate Drug (CED) and the Interim Chair for the Ontario Steering Committee of Cancer Drugs (OSCCD), Ontario MOHLTC and Ontario Health (Cancer Care Ontario). He is also the Clinical Lead for the Provincial Drug Reimbursement Programs (PDRP) at Ontario Health (Cancer Care Ontario).
Dr. Rebecca Mercer, PhD (ARCC Program Manager)
Rebecca Mercer is the Network Manager for the Canadian Centre for Applied Research in Cancer Control (ARCC). Rebecca works as a Research Lead with Ontario Health, under the Provincial Drug Reimbursement Programs. She has significant experience with knowledge translation, and an interest in facilitating information transfer among stakeholders. Rebecca received her PhD in Medical Genetics from the University of Alberta in 2012, and also holds an Honours BSc in Biomedical Sciences from the University of Guelph.
Dr. Stuart Peacock, DPhil - (ARCC Co-Director)
Stuart Peacock holds the Leslie Diamond Chair in Cancer Survivorship and is a Professor in the Faculty of Health Sciences, Simon Fraser University. He is currently Co-Director of the Canadian Centre for Applied Research in Cancer Control (ARCC). ARCC is a pan-Canadian research centre providing interdisciplinary leadership in health economics, services, policy and ethics research. Stuart is also a Distinguished Scientist in Cancer Control Research at the BC Cancer Agency, a member of the Board of Directors of the Canadian Agency for Drugs and Technologies in Health, and past President of the International Society on Priorities in Health Care. He has held university positions in Canada, Australia and the UK. Over the past 20 years, Stuart’s main research interests have focused on research into developing more effective cancer services, making health system funding decisions fairer and more transparent, and improving the quality of life of cancer patients and survivors.